ProfileGDS4459 / ENSG00000110344
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 91% 91% 95% 90% 95% 91% 92% 96% 94% 93% 93% 92% 94% 87% 95% 89% 90% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.2491
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 27.2291
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.1795
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.9290
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.1995
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 67.4591
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.6492
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.3996
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.9994
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.8293
GSM623474group B, liver allograft wedge biopsie placebo treatment 17.8993
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.7892
GSM623476group B, liver allograft wedge biopsie placebo treatment 38.0294
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.6287
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.1895
GSM623479group B, liver allograft wedge biopsie placebo treatment 67.0189
GSM623480group B, liver allograft wedge biopsie placebo treatment 77.290